Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Foghorn Therapeutics Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 45 | 39 | −6 |
| Shares | 23.3M | 23.9M | +588.7K (+2.5%) |
| Value | $306.7M | $255.1M | −$51.5M (−16.8%) |
New holders (3)
Institutions that held Foghorn Therapeutics Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rhumbline Advisers | 15,659 | $167.0K | 0.00% |
| NewSquare Capital LLC | 5,000 | $53.0K | 0.01% |
| Signaturefd, LLC | 76 | $1.00K | 0.00% |
Sold out (9)
Institutions that held Foghorn Therapeutics Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Cormorant Asset Management, LP | 1,000,000 | $13.2M |
| Point72 Asset Management, L.P. | 109,200 | $1.44M |
| Pictet Asset Management Ltd | 98,085 | $1.29M |
| Octagon Capital Advisors LP | 69,132 | $911.0K |
| Board of Trustees of The Leland Stanford Junior University | 30,657 | $404.0K |
| Victory Capital Management Inc | 16,190 | $213.0K |
| UBS Group AG | 2,136 | $28.0K |
| TFC Financial Management | 280 | $4.00K |
| Bank of Montreal | 222 | $3.00K |